# Individualized Neuromodulation of Craving Control for Meth Use Disorders

> **NCT06695637** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Substance Use Disorders
- Methamphetamine Use Disorders

## Interventions

- **RADIATION:** active cTBS
- **RADIATION:** sham cTBS

## Key facts

- **NCT ID:** NCT06695637
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-01
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Key study staff left the university
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06695637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06695637, "Individualized Neuromodulation of Craving Control for Meth Use Disorders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06695637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*